miR145 Targets the SOX9/ADAM17 Axis to Inhibit Tumor-Initiating Cells and IL-6-Mediated Paracrine Effects in Head and Neck Cancer.

MLA

Cheng-Chia Yu, et al. “MiR145 Targets the SOX9/ADAM17 Axis to Inhibit Tumor-Initiating Cells and IL-6-Mediated Paracrine Effects in Head and Neck Cancer.” Cancer Research, vol. 73, no. 11, June 2013, pp. 3425–40. EBSCOhost, https://doi.org/10.1158/0008-5472.CAN-12-3840.

APA

Cheng-Chia Yu, Lo-Lin Tsai, Mong-Lien Wang, Chuan-Hang Yu, Wen-Liang Lo, Yun-Ching Chang, Guang-Yuh Chiou, Ming-Yung Chou, & Shih-Hwa Chiou. (2013). miR145 Targets the SOX9/ADAM17 Axis to Inhibit Tumor-Initiating Cells and IL-6-Mediated Paracrine Effects in Head and Neck Cancer. Cancer Research, 73(11), 3425–3440. https://doi.org/10.1158/0008-5472.CAN-12-3840

Chicago

Cheng-Chia Yu, Lo-Lin Tsai, Mong-Lien Wang, Chuan-Hang Yu, Wen-Liang Lo, Yun-Ching Chang, Guang-Yuh Chiou, Ming-Yung Chou, and Shih-Hwa Chiou. 2013. “MiR145 Targets the SOX9/ADAM17 Axis to Inhibit Tumor-Initiating Cells and IL-6-Mediated Paracrine Effects in Head and Neck Cancer.” Cancer Research 73 (11): 3425–40. doi:10.1158/0008-5472.CAN-12-3840.